[go: up one dir, main page]

MX2013002171A - Producto simbiotico. - Google Patents

Producto simbiotico.

Info

Publication number
MX2013002171A
MX2013002171A MX2013002171A MX2013002171A MX2013002171A MX 2013002171 A MX2013002171 A MX 2013002171A MX 2013002171 A MX2013002171 A MX 2013002171A MX 2013002171 A MX2013002171 A MX 2013002171A MX 2013002171 A MX2013002171 A MX 2013002171A
Authority
MX
Mexico
Prior art keywords
synbiotic
spore
relates
present
synbiotic product
Prior art date
Application number
MX2013002171A
Other languages
English (en)
Other versions
MX348937B (es
Inventor
Richard W Rmentrout
Original Assignee
Tate & Lyle Ingredients
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tate & Lyle Ingredients filed Critical Tate & Lyle Ingredients
Publication of MX2013002171A publication Critical patent/MX2013002171A/es
Publication of MX348937B publication Critical patent/MX348937B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/40—Mineral licks, e.g. salt blocks
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/163—Sugars; Polysaccharides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Animal Husbandry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Nutrition Science (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physiology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fodder In General (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Feed For Specific Animals (AREA)

Abstract

La presente invención se relaciona con una composición de producto simbiótico que comprende una mezcla de un carbohidrato prebiótico y una bacteria Bacillus probiótico formadora de esporas: los ejemplos de carbohidratos prebióticos útiles en el producto simbiótico incluyen arabinoxilán, oligosacáridos de arabinoxilán, xilosa, dextrina de fibra soluble, fibra de maíz soluble y polidextrosa: la presente invención se relaciona con productos alimenticios para seres humanos y alimentos para animales que comprenden dichos productos simbióticos y métodos para aumentar la titulación de bacterias formadoras de esporas en los tractos intestinales de los mamíferos mediante la administración de productos simbióticos.
MX2013002171A 2010-08-25 2011-08-19 Producto simbiotico. MX348937B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US37688810P 2010-08-25 2010-08-25
PCT/US2011/048392 WO2012027214A1 (en) 2010-08-25 2011-08-19 Synbiotic product

Publications (2)

Publication Number Publication Date
MX2013002171A true MX2013002171A (es) 2013-04-05
MX348937B MX348937B (es) 2017-07-03

Family

ID=44533204

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013002171A MX348937B (es) 2010-08-25 2011-08-19 Producto simbiotico.

Country Status (11)

Country Link
US (2) US9237763B2 (es)
EP (1) EP2608678A1 (es)
JP (2) JP2013537431A (es)
KR (1) KR20130102541A (es)
CN (2) CN107251988A (es)
AU (2) AU2011293625B2 (es)
BR (1) BR112013004194A2 (es)
CA (1) CA2808495A1 (es)
IL (1) IL224833A (es)
MX (1) MX348937B (es)
WO (1) WO2012027214A1 (es)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2323669B2 (en) * 2008-08-18 2018-07-18 BioActor B.V. Arabinoxylan for modulating the barrier function of the intestinal surface
US9125935B1 (en) 2011-05-31 2015-09-08 Nutech Ventures Probiotics and methods of obtaining same
US20150313952A1 (en) * 2012-11-29 2015-11-05 Nestec S.A. Synbiotic composition and use thereof
JP6552416B2 (ja) * 2013-02-06 2019-07-31 エンヴェラ エルアイシー， エルエルシー 乾燥した芽胞発芽性化合物の混合物
EP2769626A1 (en) * 2013-02-25 2014-08-27 Cargill, Incorporated Chewing gum composition
EP2769625A1 (en) * 2013-02-25 2014-08-27 Cargill, Incorporated Confectionery compositions
GB201312713D0 (en) 2013-03-22 2013-08-28 Weaver Connie M Uses of soluble corn fibre for increasing colonic bacteria populations and increasing mineral absorption
BR112016008993B1 (pt) 2013-10-25 2021-08-31 Nch Corporation Composição probiótica para tratar animais, plantas, ou camas para animais, sistema para administrar uma composição probiótica, e, método para aumentar populações bacterianas benéficas nos tratos gastrointestinais de animais
US10766799B2 (en) 2014-05-23 2020-09-08 Nch Corporation Method for improving quality of aquaculture pond water using a nutrient germinant composition and spore incubation method
PE20170238A1 (es) 2014-05-23 2017-04-05 Nch Corp Metodo para la mejora de la calidad del agua de estanques para acuicultura
EP2805630A1 (en) * 2014-09-25 2014-11-26 Cargill, Incorporated Carbohydrate compositions
WO2017063909A1 (en) 2015-10-13 2017-04-20 Unilever N.V. A process for preparing metabolites by reaction of a prebiotic component with a probiotic component
US10897922B2 (en) 2016-04-05 2021-01-26 Nch Corporation Composition and method for germinative compounds in probiotic food and beverage products for human consumption
CN108884434B (zh) 2016-04-05 2023-06-09 Nch公司 富含营养的萌发剂组合物及孢子培养方法
US12097226B2 (en) 2016-04-05 2024-09-24 Nch Corporation System and method for using a single-serve nutrient spore composition for small scale farm applications
CN106689798B (zh) * 2016-11-17 2021-03-30 大连理工大学 海洋合生元添加剂及其制备方法与在刺参养殖中的应用
WO2018191206A1 (en) * 2017-04-10 2018-10-18 Kibow Biotech Inc. Multifiber prebiotic composition for digestive health, weight control, boosting immunity and improving health
CN107198250B (zh) * 2017-05-23 2019-03-12 北京瑞千景科技发展有限公司 改善肠道微生态预防慢性病组合物和均衡营养食品及应用
WO2019147799A1 (en) 2018-01-24 2019-08-01 Omnigen Research, Llc Bacillus combination for administration to animals
WO2019154849A1 (en) * 2018-02-06 2019-08-15 Twentygreen Solutions Ag Method of preparing prebiotic dietary fiber and probiotic-fibre complexes
US11401500B2 (en) 2018-08-29 2022-08-02 Nch Corporation System, method, and composition for incubating spores for use in aquaculture, agriculture, wastewater, and environmental remediation applications
WO2020173963A1 (en) * 2019-02-25 2020-09-03 Servophil AG Deposition reduction
CN114423442B (zh) * 2019-09-16 2024-12-03 诺维信公司 在狗中的基于孢子的益生菌补充和内毒素血症的控制
WO2021159068A1 (en) 2020-02-06 2021-08-12 Nch Corportion Composition and method of using germinative compounds in probiotics for inflammation reduction in humans
WO2021205242A1 (en) 2020-04-09 2021-10-14 Pandurangan Prabhakaran A therapeutic composition
US12109195B2 (en) * 2020-06-30 2024-10-08 Vireo Systems, Inc. Compositions and methods for treatment of vaginal infections
CN112753988A (zh) * 2021-01-22 2021-05-07 上海沛藤生物工程有限公司 一种利用芽孢杆菌的小包装甜味剂及其制备方法
TR2022004759A2 (tr) * 2022-03-28 2022-04-21 Sayar Organik Biyolojik Ueruenler Imalat Sanayi Ve Ticaret Ltd Sirketi Bacillus subtilis bakteri̇ ai̇lesi̇ i̇çeri̇kli̇ bi̇yoteknoloji̇k ürün
KR20250105751A (ko) 2023-12-29 2025-07-09 매일유업 주식회사 모유 올리고당 혼합물 및 프로바이오틱 균주를 유효성분으로 포함하는 신바이오틱 조성물

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4110477A (en) 1977-05-13 1978-08-29 Kabushiki Kaisha Naruse Fermentation Laboratory Method for producing natto containing lactic acid bacteria
JP2779963B2 (ja) 1989-02-09 1998-07-23 株式会社林原生物化学研究所 ビフィズス菌増殖促進剤
US6645506B1 (en) * 1997-04-18 2003-11-11 Ganeden Biotech, Inc. Topical compositions containing extracellular products of Pseudomonas lindbergii and Emu oil
US6203797B1 (en) 1998-01-06 2001-03-20 Stephen C. Perry Dietary supplement and method for use as a probiotic, for alleviating the symptons associated with irritable bowel syndrome
US6811786B1 (en) * 1999-04-01 2004-11-02 Ganeden Biotech, Inc. Methods for reducing cholesterol using Bacillus coagulans spores, systems and compositions
CA2326874C (en) * 1998-04-01 2010-05-25 Ganeden Biotech, Inc. Methods for reducing cholesterol using bacillus coagulans spores, systems and compositions
US6942754B2 (en) 1999-03-23 2005-09-13 Oji Paper Co., Ltd. Process for producing xylooligosaccharide from lignocellulose pulp
US6849256B1 (en) 1999-11-08 2005-02-01 Ganeden Biotech Incorporated Inhibition of pathogens by probiotic bacteria
EP1243273A1 (en) * 2001-03-22 2002-09-25 Societe Des Produits Nestle S.A. Composition comprising a prebiotic for decreasing infammatory process and abnormal activation of non-specific immune parameters
US20030077255A1 (en) 2001-04-16 2003-04-24 Sabharwal Hemant K. Compositions of bacteria and alpha-lactalbumin and uses thereof
DE60231322D1 (de) 2001-11-12 2009-04-09 Mars Inc Nahrungsmittel für katzen und hunde
GB0229015D0 (en) 2002-12-12 2003-01-15 Novartis Nutrition Ag New Compound
KR20060056991A (ko) * 2003-08-14 2006-05-25 더 바이오 밸런스 코포레이션 박테리아 균주, 이를 포함하는 조성물 및 이들의 용도
US7759105B2 (en) 2003-08-29 2010-07-20 Cobb & Company, Llp Probiotic composition useful for dietary augmentation and/or combating disease states and adverse physiological conditions
GB0414655D0 (en) 2004-06-30 2004-08-04 Leuven K U Res & Dev Prebiotic
JP5030960B2 (ja) 2005-10-24 2012-09-19 ネステク ソシエテ アノニム 食物繊維製剤及び投与方法
CN100360658C (zh) * 2006-02-17 2008-01-09 哈尔滨美华生物技术股份有限公司 肠道微生态制剂及其制备方法
CN101095698B (zh) 2006-06-26 2010-12-01 青岛东海药业有限公司 酪酸梭菌防治便臭毒素引起的相关症状和疾病的用途
EP2154992A2 (en) 2007-05-23 2010-02-24 Tate & Lyle Ingredients Americas, Inc. Edible composition comprising a slowly digestible or digestion resistant oligosaccharide composition
CN101558824B (zh) * 2008-04-15 2011-09-21 北京大北农科技集团股份有限公司 一种复合微生态制剂
US20110318455A1 (en) * 2008-08-04 2011-12-29 Elger Funda Production of beadlets comprising probiotic compounds
CN101744239A (zh) 2008-12-01 2010-06-23 青岛东海药业有限公司 膳食纤维在制备防治便臭或便臭中毒综合征制剂中的应用
CN101449830B (zh) * 2008-12-29 2012-01-11 山东龙力生物科技股份有限公司 一种添加合生元的中老年奶粉及其制备方法
CN101537020B (zh) 2009-04-24 2012-05-02 东北制药集团公司沈阳第一制药厂 地衣芽孢杆菌与寡糖类益生元的合生元及其组合物和制剂
BRPI1014800A8 (pt) * 2009-05-07 2016-10-11 Tate & Lyle Ingredients France SAS "composição compreendendo alfa-(1,6) oligodextranas alfa-(1,2) ramificadas, método para preparar as referidas oligodextranas e uso das mesmas"
US12436408B2 (en) 2022-11-11 2025-10-07 Htc Corporation Wearable device

Also Published As

Publication number Publication date
WO2012027214A1 (en) 2012-03-01
BR112013004194A2 (pt) 2016-05-10
EP2608678A1 (en) 2013-07-03
KR20130102541A (ko) 2013-09-17
IL224833A (en) 2017-03-30
CN103068254A (zh) 2013-04-24
MX348937B (es) 2017-07-03
US20120052152A1 (en) 2012-03-01
AU2011293625A1 (en) 2013-02-21
AU2011293625B2 (en) 2015-09-24
JP2013537431A (ja) 2013-10-03
AU2015271936A1 (en) 2016-02-11
JP2017113022A (ja) 2017-06-29
CA2808495A1 (en) 2012-03-01
US20160095343A1 (en) 2016-04-07
CN107251988A (zh) 2017-10-17
US9237763B2 (en) 2016-01-19

Similar Documents

Publication Publication Date Title
MX348937B (es) Producto simbiotico.
PH12016501953A1 (en) Pediatric nutritional composition with human milk oligosaccharides, prebiotics and probiotics
Chen et al. Lactose and lactose-derived oligosaccharides: More than prebiotics?
JP2013537431A5 (es)
MY144315A (en) Beta-galactosidase with transgalactosylating activity
NZ612386A (en) Synbiotic combination of probiotic and human milk oligosaccharides to promote growth of beneficial microbiota
UA100985C2 (ru) Композиция для питания с нежизнеспособной бифидобактерией и неусваиваемым олигосахаридом
MY187609A (en) Human milk oligosaccharides to ameliorate symptoms of stress
NZ602249A (en) Food comprising glucomannan, xanthan gum and alginate for the treatment of metabolic disorders
PH12014502811A1 (en) Dietary management of celiac disease and food allergy
ZA200806175B (en) Galactosidalse with alpha-galactosyltransferase activity
Sharma et al. Pre-and probiotics: Using functional foods in the fight against microbial resistance to antibiotics
WO2011154820A3 (en) Vitamin b12 producing probiotic bacterial strains
Coppa et al. Human milk glycosaminoglycans as possible bioactive substances for the breastfed newborn
UA101726C2 (ru) Средство для профилактики и лечения сахарного диабета

Legal Events

Date Code Title Description
HH Correction or change in general
FG Grant or registration